Zeke Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-899	Closed	-$31K	–	647
2018 Q1	$31K	Sell	899 -284	-24%	-$9.79K	﹤0.01%	644
2017 Q4	$50K	Buy	1,183 +512	+76%	+$21.6K	0.01%	553
2017 Q3	$29K	Buy	+671	New	+$29K	﹤0.01%	426